Radiopharm Theranostics RADX Income Statement (2023-2026)

NASDAQ RADX
$1.45 -0.17 (-10.49%)
As of: Oct 1, 2026 · 9:54 AM EDT
Reported Financials

Radiopharm Theranostics Quarterly Income Statement

Periods 5 quarters
Latest Jun 2026

Radiopharm Theranostics reported net income of -$40.32M for the quarter ended Jun 2026. This income statement covers 5 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Radiopharm Theranostics Income Statement API

Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RADX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY